Immune Globulin (Human)
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Anti-Hepatitis A Antibody Levels in Heathy Subjects
Conditions
Anti-Hepatitis A Antibody Levels in Heathy Subjects
Trial Timeline
Oct 31, 2017 → Jul 19, 2018
NCT ID
NCT03351933About Immune Globulin (Human)
Immune Globulin (Human) is a approved stage product being developed by Grifols for Anti-Hepatitis A Antibody Levels in Heathy Subjects. The current trial status is completed. This product is registered under clinical trial identifier NCT03351933. Target conditions include Anti-Hepatitis A Antibody Levels in Heathy Subjects.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03351933 | Approved | Completed |